HEP-COVID Clinical Trial Results on the Prevention of Blood Clots HEP-COVID Clinical Trial Results on the Prevention of Blood Clots

WebMD ' s Chief Medical Officer, John Whyte, MD, speaks with Alex Spyropoulos, MD, a thrombosis expert, on his recent HEP-COVID randomized clinical trial involving COVID-19 patients, the blood thinner heparin, and reducing the risk of major blood clots.WebMD
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases Expert Interview Source Type: news